Skip to content

Understanding the Public Impact on Dengue Vaccination Strategies in Yunnan Province, China: A Dynamic Transmission Modeling Study

Understanding the Public Impact on Dengue Vaccination Strategies in Yunnan Province, China: A Dynamic Transmission Modeling Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07206784
Enrollment
220
Registered
2025-10-03
Start date
2025-05-01
Completion date
2027-05-01
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dengue Vaccination Strategy Evaluation, Public Health Impact of Vaccination, Transmission Modeling of Dengue

Brief summary

This study is a collaboration between the School of Public Health at Fudan University and the Xishuangbanna Center for Disease Control and Prevention in Yunnan Province, China. It aims to evaluate the public health impact of dengue vaccination strategies using dynamic transmission models. By simulating different vaccination scenarios, the study will assess the potential effectiveness and public health benefits of dengue vaccine introduction, providing scientific evidence to support local dengue prevention and control efforts.

Interventions

None listed

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum

Inclusion criteria

* Resident of Jinghong City, Xishuangbanna Prefecture * Aged 3 years and above * Able and willing to provide informed consent (or have legal guardian consent for minors) * Available for blood sample collection between May and August 2025

Exclusion criteria

* Individuals with bleeding disorders or other contraindications to blood draw * Individuals currently diagnosed with acute dengue infection

Design outcomes

Primary

MeasureTime frame
Dengue Virus Serological Response (IgM and IgG Antibody Levels)From blood sample collection to the completion of laboratory analysis of dengue serology, serotype identification, and whole genome sequencing, from May to August 2025

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026